ArticleAdvances in radiation oncology

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial.

Kevin Shee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.